Search results
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
Reuters via Yahoo News· 4 days agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long...
2 Dividend Stocks Billionaires Are Buying: Should You?
Motley Fool via Yahoo Finance· 4 days agoPfizer Pfizer hasn't performed well recently. Despite its important role in developing effective...
Retiree calls out Sask. gov't for not communicating changes to accessing COVID-19 drug Paxlovid
CBC via Yahoo News· 7 days agoWhen Greg Pletz contracted COVID-19 in mid-May, he called the Saskatchewan 811 HealthLine and was...
Moderna says combination flu, COVID shot succeeds in study
BioPharma Dive via Yahoo Finance· 1 day agoDive Brief: Moderna on Monday said a combination flu and COVID-19 shot it’s developing met the goal...
New COVID variant KP.3 climbs to 25%, now largest in CDC estimates
CBS News· 4 days agoThe new KP.3 variant has climbed to 1 in 4 new COVID-19 cases nationwide, the Centers for Disease...
Why Things Could Get Worse for Pfizer Stock Before They Get Better
Motley Fool via Yahoo Finance· 6 days agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (NYSE: PFE) stock was a hot buy...
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Motley Fool via Yahoo Finance· 3 days agoBut the dividend isn't the only thing attractive about this stock. Believe it or not, Pfizer could...
Paxlovid Doesn't Cure Long COVID
Time via Yahoo News· 4 days agoPfizer's drug Paxlovid on display in Pembroke Pines, Fla., on July 7, 2022. Credit - Joe Raedle—Getty Images Taking the COVID-
Thinking Of Buying Pfizer For Its 5.8% Dividend Yield? Consider This Alternative Option Instead
Benzinga via Yahoo Finance· 4 days agoPfizer Inc. (NYSE:PFE) has long been a favorite among income investors, thanks to its generous...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 5 days agoThis approval represents a significant development in the field and is likely to encourage the use...